TSPO and amyotrophic lateral sclerosis: Overall, the results of the present study support the potential of TSPO‐PET as a noninvasive diagnostic imaging biomarker for early detection and monitoring of skeletal muscle degeneration and highlight the potential role of TSPO as a druggable target in ALS.